logo
GaldermaReceivesU.S.FDAApprovalforDifferin庐Epiduo庐AcneGelPrescription-to-OTCSwitch
===2026/5/26 0:28:20===
ne.buguet@galderma.com
+41 76 249 90 87

Viviana Wiewall
Head of U.S. Communications
viviana.wiewall@galderma.com
+1 786 451 7740

Emil Ivanov
Head of Strategy, Investor Relations, and ESG
emil.ivanov@galderma.com
+41 21 642 78 12

Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43



The U.S. FDA approves Differin庐 Epiduo庐 Acne Gel Prescription-to-OTC switch
=*=*=*=*=*=
当前为第10/10页
上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页